pharmacie et médicaments – Ataxie de Friedreich : mise sur le marché du médicament Skyclarys

This written question concerns the marketing authorization of the drug Skyclarys for the treatment of Friedreich's Ataxia. It seeks information on the process and implications of this approval. The question likely affects patients with Friedreich's Ataxia, their families, and the pharmaceutical industry involved in rare disease treatments.